Similar articles

• [Role of cyclic GMP in visnal process-activation of cyclic GMP phosphodiesterase by light and ATP (author's transl)].

  Miki N. Miki N. Tanpakushitsu Kakusan Koso. 1976 Aug 1;21(8):605-11. Tanpakushitsu Kakusan Koso. 1976. PMID: 9667 Japanese. No abstract available.
• Evidence for differences in protein kinase modulator and and phosphodiesterase activator.

  Miyamoto E, Hideshima Y, Teshima Y, Yamazaki R, Kakiuchi S. Miyamoto E, et al. J Cyclic Nucleotide Res. 1977 Apr;3(2):85-94. J Cyclic Nucleotide Res. 1977. PMID: 195987
• Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.

  Levin RM, Weiss B. Levin RM, et al. Mol Pharmacol. 1977 Jul;13(4):690-7. Mol Pharmacol. 1977. PMID: 18661 No abstract available.
• [A ubiquitous Ca-binding protein that activates cyclic nucleotide phosphodiesterase (author's transl)].

  Kasai H. Kasai H. Tanpakushitsu Kakusan Koso. 1977;22(6):680-5. Tanpakushitsu Kakusan Koso. 1977. PMID: 200978 Review. Japanese. No abstract available.
• [Regulation of cyclic AMP and cyclic GMP-dependent protein kinase activity].

  Szmigielski A. Szmigielski A. Postepy Hig Med Dosw. 1980;34(4):287-306. Postepy Hig Med Dosw. 1980. PMID: 6270641 Review. Polish. No abstract available.